LEADER 02073nmm a2200337 u 4500
001 EB001123016
003 EBX01000000000000000855899
005 00000000000000.0
007 cr|||||||||||||||||||||
008 160204 ||| eng
100 1 |a Frazier, Kendall S. 
245 0 0 |a Antisense oligonucleotides  |h Elektronische Ressource  |b the promise and the problems  |c Kendall S. Frazier 
260 |a London  |b Henry Stewart Talks  |c 2015, 2015 
300 |a 1 online resource (1 streaming video file (45 min.)  |b color, sound) 
505 0 |a Antisense oligonucleotide (ASOs) therapies -- Screening strategies for drug candidates -- Locked nucleic acid (LNA) gapmers -- Understanding off-target effects (OTEs) -- Mechanisms of ASO toxicity and clinical relevance -- New targets/delivery systems under development 
653 |a Toxicity Tests 
653 |a Patient Safety 
653 |a Drug Discovery / methods 
653 |a Oligonucleotides, Antisense / toxicity 
653 |a Antisense nucleic acids 
653 |a Oligonucleotides, Antisense / adverse effects 
653 |a Oligonucleotides, Antisense / therapeutic use 
653 |a Drug development 
653 |a Toxicity testing 
041 0 7 |a eng  |2 ISO 639-2 
989 |b HST  |a Henry Stewart Talks 
490 0 |a Future directions in therapeutic intervention, diagnostics and prophylactics 
500 |a Animated audio-visual presentation with synchronized narration. - Title from title frames. - Mode of access: World Wide Web. - System requirements: Browser compatibility: updated Mozilla Firefox, Google Chrome, Safari or Internet Explorer 8+. Browser settings: enable JavaScript, enable cookies from the Henry Stewart Talks site. Required Desktop Browser plugins & viewers: Updated Adobe Flash Player & Adobe Acrobat Reader. Mobile device & operating system versions: Android v4.0+, iPhone 4+ (iOS v6.x+), iPad 2+ (iOS v6.x+), BlackBerry OS v7.0+, Windows Phone v6.5.1+ 
856 4 0 |u https://hstalks.com/bs/3174  |x Verlag  |z Streaming video file 
856 4 2 |u https://hstalks.com/bs/p/1027  |3 Series 
082 0 |a 570